These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 3927867)

  • 1. Pseudomonas bacteremia. Retrospective analysis of 410 episodes.
    Bodey GP; Jadeja L; Elting L
    Arch Intern Med; 1985 Sep; 145(9):1621-9. PubMed ID: 3927867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical characteristics and outcomes of Pseudomonas aeruginosa bacteremia in febrile neutropenic children and adolescents with the impact of antibiotic resistance: a retrospective study.
    Kim HS; Park BK; Kim SK; Han SB; Lee JW; Lee DG; Chung NG; Cho B; Jeong DC; Kang JH
    BMC Infect Dis; 2017 Jul; 17(1):500. PubMed ID: 28716109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent experience with Pseudomonas aeruginosa bacteremia in patients with cancer: Retrospective analysis of 245 episodes.
    Chatzinikolaou I; Abi-Said D; Bodey GP; Rolston KV; Tarrand JJ; Samonis G
    Arch Intern Med; 2000 Feb; 160(4):501-9. PubMed ID: 10695690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pseudomonas aeruginosa bacteremia associated with hematologic disorders [III]. Prognostic factors].
    Funada H; Machi T; Matsuda T
    Kansenshogaku Zasshi; 1989 Aug; 63(8):880-5. PubMed ID: 2507688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serratia bacteremia: review of 118 cases.
    Saito H; Elting L; Bodey GP; Berkey P
    Rev Infect Dis; 1989; 11(6):912-20. PubMed ID: 2602776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pseudomonas aeruginosa bacteraemia. Is pancreatobiliary disease a risk factor?
    Chen SC; Lawrence RH; Byth K; Sorrell TC
    Med J Aust; 1993 Nov; 159(9):592-7. PubMed ID: 8232033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review of Citrobacter bacteremia in cancer patients over a sixteen-year period.
    Samonis G; Anaissie E; Elting L; Bodey GP
    Eur J Clin Microbiol Infect Dis; 1991 Jun; 10(6):479-85. PubMed ID: 1915382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pseudomonas aeruginosa septicemia in childhood cancer patients.
    Jackson MA; Wong KY; Lampkin B
    Pediatr Infect Dis; 1982; 1(4):239-41. PubMed ID: 7177913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. β-Lactam plus aminoglycoside or fluoroquinolone combination versus β-lactam monotherapy for Pseudomonas aeruginosa infections: a meta-analysis.
    Vardakas KZ; Tansarli GS; Bliziotis IA; Falagas ME
    Int J Antimicrob Agents; 2013 Apr; 41(4):301-10. PubMed ID: 23410791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Occurrence of antipseudomonal beta-lactams and aminoglycosides resistance in Pseudomonas aeruginosa during therapy.
    Pagani L; Scarabelli M; Cereda PM; Debiaggi M
    Microbiologica; 1987 Jan; 10(1):103-10. PubMed ID: 3106759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pseudomonas aeruginosa bacteremia associated with hematologic disorders [II]. Blood culture isolates and surveillance cultures].
    Funada H; Machi T; Matsuda T
    Kansenshogaku Zasshi; 1989 Aug; 63(8):874-9. PubMed ID: 2507687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative review of combination therapy: two beta-lactams versus beta-lactam plus aminoglycoside.
    DeJace P; Klastersky J
    Am J Med; 1986 Jun; 80(6B):29-38. PubMed ID: 3524218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Community-acquired Pseudomonas aeruginosa sepsis in previously healthy infants and children: analysis of forty-three episodes.
    Huang YC; Lin TY; Wang CH
    Pediatr Infect Dis J; 2002 Nov; 21(11):1049-52. PubMed ID: 12442028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a combination antibiogram for Pseudomonas aeruginosa bacteremia in an oncology population.
    Smith ZR; Tajchman SK; Dee BM; Bruno JJ; Qiao W; Tverdek FP
    J Oncol Pharm Pract; 2016 Jun; 22(3):409-15. PubMed ID: 25956419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Addition of rifampin to combination antibiotic therapy for Pseudomonas aeruginosa bacteremia: prospective trial using the Zelen protocol.
    Korvick JA; Peacock JE; Muder RR; Wheeler RR; Yu VL
    Antimicrob Agents Chemother; 1992 Mar; 36(3):620-5. PubMed ID: 1622173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pseudomonas spp. complications in patients with HIV disease: an eight-year clinical and microbiological survey.
    Manfredi R; Nanetti A; Ferri M; Chiodo F
    Eur J Epidemiol; 2000 Feb; 16(2):111-8. PubMed ID: 10845259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of definitive therapy with beta-lactam monotherapy or combination with an aminoglycoside or a quinolone for Pseudomonas aeruginosa bacteremia.
    Bliziotis IA; Petrosillo N; Michalopoulos A; Samonis G; Falagas ME
    PLoS One; 2011; 6(10):e26470. PubMed ID: 22046290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of empiric aminoglycoside monotherapy for Pseudomonas aeruginosa bacteremia.
    Phe K; Bowers DR; Babic JT; Tam VH
    Diagn Microbiol Infect Dis; 2019 Apr; 93(4):346-348. PubMed ID: 30522794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An evaluation of antipseudomonal antimicrobic agents.
    Gilbert DN
    Antibiot Chemother (1971); 1985; 36():111-33. PubMed ID: 3923909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pseudomonas aeruginosa bacteremia: univariate and multivariate analyses of factors influencing the prognosis in 133 episodes.
    Bisbe J; Gatell JM; Puig J; Mallolas J; Martinez JA; Jimenez de Anta MT; Soriano E
    Rev Infect Dis; 1988; 10(3):629-35. PubMed ID: 3393785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.